SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 181 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $244,000 | +3.0% | 20,664 | -4.3% | 0.00% | 0.0% |
Q1 2017 | $237,000 | -68.0% | 21,590 | -60.5% | 0.00% | -50.0% |
Q4 2016 | $741,000 | +49.1% | 54,700 | +118.8% | 0.00% | +33.3% |
Q3 2015 | $497,000 | -46.8% | 25,000 | -58.4% | 0.00% | -40.0% |
Q1 2015 | $935,000 | – | 60,054 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 2,803,138 | $30,835,000 | 9.94% |
Redwood Investments, LLC | 603,176 | $6,635,000 | 0.66% |
ALGERT GLOBAL LLC | 205,529 | $2,261,000 | 0.61% |
Nine Chapters Capital Management LLC | 40,500 | $446,000 | 0.60% |
Malaga Cove Capital, LLC | 84,269 | $897,000 | 0.54% |
CLARK ESTATES INC/NY | 250,000 | $2,750,000 | 0.42% |
AlphaMark Advisors, LLC | 78,500 | $864,000 | 0.40% |
Ativo Capital Management LLC | 109,023 | $1,199,000 | 0.30% |
GLOBEFLEX CAPITAL L P | 103,949 | $1,143,000 | 0.27% |
Piermont Capital Management Inc. | 65,959 | $726,000 | 0.17% |